COVID-19 Oral Pill Therapeutic Vaccine Found Promising in Early Study
January 18, 2021
(Precision Vaccinations)
New York-based Key Capital Corporation announced independent laboratory testing of its partnered Immunitor COVID-19 patented oral pill vaccine in an ongoing university study is providing promising early support for the safety and efficacy of the vaccine.
